Press Release · Press Releases
Johnson & Johnson reports 73% PSA response rate with investigational pasritamig-based immunotherapy combination in advanced prostate cancer
First-of-its-kind dual-antigen-targeted bispecific regimen of pasritamig and JNJ-9401 directed at two prostate cancer proteins, KLK2 and PSMA, using complementary signals to activate T cells against cancer Deep and sustained PSA responses observed with every-six-week dosing, with 73% (11...
This press release summary is reproduced from the issuer's public feed.
Read the full release at PR NewswireOriginal publisher: PR Newswire
Spotted an error? Request a correction · Corrections Policy
Related stories
Allergan Aesthetics Reports Improved Satisfaction With Facial Appearance Following Aesthetic Treatment in Two Studies of Patients on GLP-1 Medications
– HARMONY IN DIVERSITY is the first study of combined neurotoxin and filler treatment in adults on glucagon-like peptide-1 (GLP-1) medications. In this Phase 4 cohort, participants reported statistically significant improvements in satisfaction with facial appearance and skin quality...
PR Newswire ·
Cleaner Bedroom Air May Help Manage Blood Sugar in Prediabetes
NEW YORK, Nov. 8, 2026 /PRNewswire/ -- Using portable filters to reduce exposure to air pollution during sleep may stabilize the large spikes in blood sugar experienced by people with prediabetes, a condition in which sugar (glucose) levels are higher than normal, a new study shows....
PR Newswire ·
Amplifon Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Social Security Numbers and Health Records Are Exposed
National class action law firm offers free, confidential case evaluations to Amplifon hearing-care members, patients, and others whose information may have been exposed. NEWTOWN, Pa., Nov. 8, 2026 /PRNewswire/ -- Edelson Lechtzin LLP, a national class action law firm, is investigating...
PR Newswire ·
GIL INVESTOR NOTICE: Gildan Activewear Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before December 14, 2026 Deadline
SAN DIEGO, Nov. 8, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Gildan Activewear Inc. (NYSE: GIL) publicly traded securities between February 19, 2025 and June 15, 2026, both dates inclusive (the "Class Period"), have...
PR Newswire ·
Le GSMA MWC26 Doha ouvre ses portes avec un appel à l'harmonisation des normes industrielles mondiales et à la réduction de la fracture numérique au Moyen-Orient et en Afrique du Nord
Des opérateurs, des leaders technologiques, des décideurs politiques et des innovateurs se réunissent aujourd'hui à Doha pour trois jours d'exposition, de collaboration et de débats sur l'avenir de la connectivité au Moyen-Orient et en Afrique du Nord DOHA, Qatar, 8 novembre 2026...
PR Newswire ·
essential COSTA RICA nommée Marque territoriale de l'année aux City Nation Place Awards à Londres
Le Costa Rica a reçu trois distinctions : Marque territoriale de l'année, Meilleure mobilisation citoyenne et une mention spéciale dans la catégorie Meilleure stratégie de communication. essential COSTA RICA est la première marque nationale à recevoir deux fois le prix de la Marque...
PR Newswire ·